1.800.THE FIRM | 1.800.843.3476
The Cochran Firm Legal Blog
With Office Locations Nationwide
Tuesday, May 4, 2010
Baxter Recalls Defective Medical Product
A defective medical product is being withdrawn from the U.S. market under an agreement between the manufacturer and the Food and Drug Administration, or FDA.
Baxter Healthcare Corp., the main American subsidiary of Baxter International, has announced the recall of its Colleague infusion pump. "There are just under 200,000 of these pumps in use" at hospitals and other medical facilities, according to Baxter spokeswoman Erin Gardiner.
She said that Colleague pumps will be phased out, and that the model has not been sold to new customers since 2005. Baxter will exchange its Sigma Spectrum pump for the Colleague model, she said.
The FDA on April 30 said a Baxter plan to keep the pumps in use until 2013 was "unacceptable." On April 23, the FDA said that infusion pumps used to administer drugs and liquids were linked to more than 56,000 complaints of injuries, deaths, and malfunctions between 2005 and 2009.
One function of this infusion pump is to deliver nutrients to patients in comas, who obviously are in no position to speak up for themselves. Imagine the grief and anger that a family would feel if it learned that the very products they were relying on to sustain their loved ones caused personal injury, or even death, instead.
At The Cochran Firm, we stand ready to seek justice when average citizens fall victim to defective products or services. If you wish to discuss a possible claim of this kind, or just want to know more about how we can help you, please contact us for a no-obligation discussion at any of our nationwide offices.
Baxter Healthcare Corp., the main American subsidiary of Baxter International, has announced the recall of its Colleague infusion pump. "There are just under 200,000 of these pumps in use" at hospitals and other medical facilities, according to Baxter spokeswoman Erin Gardiner.
She said that Colleague pumps will be phased out, and that the model has not been sold to new customers since 2005. Baxter will exchange its Sigma Spectrum pump for the Colleague model, she said.
The FDA on April 30 said a Baxter plan to keep the pumps in use until 2013 was "unacceptable." On April 23, the FDA said that infusion pumps used to administer drugs and liquids were linked to more than 56,000 complaints of injuries, deaths, and malfunctions between 2005 and 2009.
One function of this infusion pump is to deliver nutrients to patients in comas, who obviously are in no position to speak up for themselves. Imagine the grief and anger that a family would feel if it learned that the very products they were relying on to sustain their loved ones caused personal injury, or even death, instead.
At The Cochran Firm, we stand ready to seek justice when average citizens fall victim to defective products or services. If you wish to discuss a possible claim of this kind, or just want to know more about how we can help you, please contact us for a no-obligation discussion at any of our nationwide offices.
Labels: main
posted by Benjamin A. Irwin at 9:59 AM
<< Home